S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.60%)
CGC   17.64 (+15.14%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
T   37.18 (-2.16%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
BAC   32.69 (-0.76%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.60%)
CGC   17.64 (+15.14%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
T   37.18 (-2.16%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
BAC   32.69 (-0.76%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.60%)
CGC   17.64 (+15.14%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
T   37.18 (-2.16%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
BAC   32.69 (-0.76%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.60%)
CGC   17.64 (+15.14%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
T   37.18 (-2.16%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
BAC   32.69 (-0.76%)
DIS   146.93 (-0.98%)
Log in

Teva Pharmaceutical Industries Earnings Date, Estimates & History (NYSE:TEVA)

$10.42
+0.13 (+1.26 %)
(As of 11/20/2019 04:00 PM ET)
Today's Range
$10.11
Now: $10.42
$10.52
50-Day Range
$6.55
MA: $8.06
$10.35
52-Week Range
$6.07
Now: $10.42
$22.29
Volume16.53 million shs
Average Volume25.80 million shs
Market Capitalization$11.38 billion
P/E Ratio3.72
Dividend YieldN/A
Beta1.73

Earnings

Teva Pharmaceutical Industries (NYSE:TEVA) Earnings Information

Teva Pharmaceutical Industries last issued its quarterly earnings results on November 7th, 2019. The reported $0.56 earnings per share for the quarter, missing the consensus estimate of $0.58 by $0.02. The company earned $4.26 billion during the quarter, compared to the consensus estimate of $4.25 billion. Teva Pharmaceutical Industries has generated $2.80 earnings per share over the last year and currently has a price-to-earnings ratio of 3.7. Teva Pharmaceutical Industries has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2020 based off prior year's report dates.

Teva Pharmaceutical Industries Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Teva Pharmaceutical Industries (NYSE:TEVA) Earnings Estimates

2019 EPS Consensus Estimate: $2.53
2020 EPS Consensus Estimate: $2.35
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20193$0.61$0.73$0.66
Q2 20193$0.55$0.71$0.62
Q3 20194$0.56$0.67$0.62
Q4 20193$0.57$0.67$0.63
Q1 20201$0.62$0.62$0.62
Q2 20201$0.59$0.59$0.59
Q3 20201$0.57$0.57$0.57
Q4 20201$0.57$0.57$0.57

Teva Pharmaceutical Industries (NYSE TEVA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/12/2020
(Estimated)
       
11/7/2019Q3 2019$0.58$0.56$1.41$4.25 billion$4.26 billionTranscript
8/7/20196/30/2019$0.55$0.57$1.77$4.25 billion$4.34 billionListen
5/2/20193/31/2019$0.55$0.57$1.24$4.38 billion$4.30 billionListen
2/13/201912/31/2018$0.53$0.53$3.95$4.52 billion$4.56 billionN/A
11/1/20189/30/2018$0.53$0.64$1.55$4.54 billion$4.53 billionN/A
8/2/20186/30/2018$0.64$0.78$1.74$4.75 billion$4.70 billionN/A
5/3/20183/31/2018$0.63$0.91$0.79$4.80 billion$5.07 billionN/A
2/8/2018Q4 17$0.77$0.91$13.23$5.29 billion$5.46 billionTranscript
11/2/2017Q3 2017$1.03$0.95$1.38$5.61 billion$5.61 billionN/A
8/3/20176/30/2017$1.06$0.99$7.92$5.72 billion$5.69 billionListen
5/11/2017Q1 17$1.06$1.06$1.49$5.69 billion$5.63 billionN/A
2/13/2017Q4 2016$1.32$1.36$3.82$6.26 billion$6.25 billionN/A
11/15/2016Q3 2016$1.28$1.28$2.21$5.71 billion$5.56 billionN/A
8/4/2016Q2 2016$1.18$1.25$2.30$4.86 billion$5.00 billionN/A
5/9/2016Q1 2016$1.13$1.18$1.74$4.78 billion$4.81 billionN/A
2/11/2016Q4 2015$1.28$1.28$2.01$4.83 billion$4.88 billionListen
10/29/2015Q3 2015$1.29$1.35$2.58$4.75 billion$4.80 billionListen
7/30/2015Q2 2015$1.31$1.43$2.23$4.90 billion$4.97 billionListen
4/30/2015Q1 2015$1.26$1.36$2.20$4.84 billion$5.00 billionN/A
2/5/2015Q4 2014$1.30$1.31$1.82$5.17 billion$5.17 billionN/A
10/30/2014Q3 2014$1.23$1.32$1.62$5.09 billion$5.06 billionN/A
7/31/2014Q2 2014$1.22$1.23$1.59$5.08 billion$5.00 billionListen
5/1/2014Q1 2014$1.23$1.22$1.57$5.11 million$5.00 billionTranscript
2/6/2014Q4 2013$1.40$1.42$2.39$5.19 billion$5.40 billionN/A
10/31/2013Q3 2013$1.26$1.27$1.70$5.00 billion$5.06 billionTranscript
8/1/2013Q2 2013$1.18$1.20$2.93$4.94 billion$4.90 billionTranscript
5/2/2013Q1 2013$1.10$1.12$1.50$4.85 billion$4.90 billionTranscript
2/7/2013Q412$1.33$1.32$5.26 billion$5.20 billionTranscript
11/1/2012Q312$1.25$1.28$5.08 billion$5.00 billionN/A
8/2/2012$1.28$1.28N/A
5/9/2012$1.44$1.47N/A
2/15/2012$1.58$1.59Listen
11/2/2011$1.22$1.25N/A
7/27/2011$1.08$1.10N/A
5/11/2011$1.03$1.04Transcript
2/8/2011$1.28$1.25N/A
11/2/2010Q3 2010$1.27$1.30$1.45N/A
7/26/2010Q2 2010$1.04$1.08$1.28N/A
5/4/2010Q1 2010$0.89$0.92$1.05N/A
2/16/2010Q4 2009$0.95$0.94$1.46N/A
11/3/2009Q3 2009$0.88$0.89$1.06N/A
7/28/2009Q2 2009$0.80$0.83$1.08N/A
5/5/2009Q1 2009$0.67$0.72$0.93N/A
2/17/2009Q4 2008$0.73$0.76$2.40N/A
11/6/2008Q3 2008$0.69$0.72$0.67N/A
7/29/2008Q2 2008$0.64$0.65$0.65N/A
5/6/2008Q1 2008$0.63$0.64$1.10N/A
2/12/2008Q4 2007$0.66$0.69$0.69N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel